American Journal of Infection Control

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, began in spring 2020 and has resulted in numerous challenges for healthcare and public health systems. In fall 2020, the Association for Professionals in Infection Control and Epidemiology (APIC)

After the first report of Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on December 31, 2019, newly developed variants have repeatedly threatened the world. Since the end of November 2021

Contact tracing is a critical strategy to control COVID-19 transmission.1 However, barriers such as program costs hinder efforts to expand contact tracing in US health departments.2 One potential solution is augmenting health departments by

Health care workers (HCW) comprise a group that is particularly affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and exposed to high viral loads, higher than the general population.1-3 Transmissibility between asymptomatic or

Health care-associated infections (HAI) are a significant cause of morbidity and health care costs, affecting over 1 million patients annually. Patient contact has been associated with contamination of health care workers’ hands or clothing and

In 2019 nearly 90,000 women had a caesarean section (CS) in Australia.1 The most common complication after a CS is surgical site infection (SSI). SSI following a CS is of concern to women as well as the health services. Infection rates vary between 4

There is a lack of attention given to research on infection prevention and control and practical guidance among people and their lives outside of health care settings, especially in impoverished communities where people live, work, and play. To stop

The Emerging Infections Program (EIP) of the Centers for Disease Control and Prevention (CDC) recently estimated from data collected at designated EIP locations that there were ∼236,000 cases of healthcare-associated Clostridioides difficile

Negative outcomes associated with COVID-19 in pregnant patients make vaccination an imperative precaution for this patient population. Pregnant patients were excluded from the randomized clinical trials conducted early in the pandemic to determine

Antibiotic overuse puts patients at risk for adverse events and contributes to global antibiotic resistance. More than 2.8 million antibiotic-resistant infections occur in the United States each year, and more than 35,000 people die as a result.1